ArticleBMC infectious diseases2025
Dyskalaemia as a predictor of mortality in sepsis: a retrospective cohort study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate the association between dyskalaemia and 30-day mortality in patients with sepsis and to determine whether potassium disturbances serve as independent prognostic markers in this population.
methodsThis retrospective cohort study included adult patients diagnosed with sepsis who were admitted to the emergency department of a tertiary hospital between January 1, 2022, and January 1, 2025. Serum potassium levels at admission were categorized as hypokalemia (< 3.5 mmol/L), normokalemia (3.5-5.0 mmol/L), and hyperkalemia (> 5.0 mmol/L). The primary outcome was 30-day all-cause mortality. Multivariate logistic regression was used to identify independent predictors of mortality, adjusting for confounders. A restricted cubic spline regression model was applied to assess the non-linear relationship between potassium levels and mortality.
resultsA total of 1,347 patients were included, of whom 305 (22.6%) died within 30 days. Both hypokalemia and hyperkalemia were significantly associated with increased mortality compared to normokalemia. Dyskalaemia was independently associated with mortality (OR = 2.10, 95% CI: 1.45-3.05, p < 0.001), and a U-shaped relationship was observed between potassium levels and mortality risk. The predictive model demonstrated good calibration (Hosmer-Lemeshow test, p = 0.584) and discrimination (AUROC = 0.840, 95% CI: 0.788-0.879).
conclusionsDyskalaemia was identified as an independent predictor of 30-day mortality in septic patients. These findings highlight the clinical relevance of potassium disturbances in early risk stratification. The observed U-shaped association between potassium levels and mortality supports the potential value of potassium as a prognostic marker. However, whether correcting dyskalaemia improves outcomes remains to be determined.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.